Thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans
Schematic model detailing how thermogenic adipose tissue activation attenuates dyslipidaemia and protects from atherosclerosis development. Activated thermogenic adipose tissue (i.e. BAT and browned WAT) burns FAs liberated from intracellular lipid droplets for heat production. To replenish intracellular triglyceride stores, thermogenic adipose tissue takes up FAs from circulating TRLs after liberation by LPL-mediated lipolysis (pathway 1), leaving TRL core remnants and TRL surface remnants, mainly phospholipids, in the circulation. The core remnants are then efficiently taken up by the liver after binding of ApoE on the particle surface to mainly the LDLR on hepatocytes (pathway 2), protein levels of which are regulated by proprotein convertase subtilisin/kexin type 9 (PCSK9), resulting in a reduction in cholesterol-enriched lipoproteins and therefore attenuating trapping of lipoproteins in artery walls and atherosclerosis progression. The surface remnants are sequestered into HDL to improve HDL’s cholesterol efflux-inducing capacity from e.g. macrophages in atherosclerotic plaques, with subsequent esterification of the acquired cholesterol by LCAT and selective delivery of the cholesteryl esters via SRB1 to hepatocytes (pathway 3), which can contribute to the atheroprotective effect of thermogenic adipose tissue activation. The uptake of cholesterol-enriched TRL remnants and cholesteryl esters from HDL combined leads to the accumulation of cholesterol in the liver, which drives cholesterol conversion into bile acids (pathway 4) with increased bile acid excretion via faeces (pathway 6), an effect that is attenuated upon prolonged stimulation of thermogenesis in adipose tissue due to enhanced bile acid re-uptake via enterohepatic circulation (pathway 5). See text for more details.
Publication
Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans. (2023) Zhixiong Ying, et al. Cardiovasc Res. 2023 Apr;119(4):905-918. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Mus musculus | Rodents | B-AR | B-AR | ncbigene_synonym | Adrb1 | 11554 |
| Mus musculus | Rodents | TRL | TRL | ncbigene_synonym | T(10;11)Rl | 21032 |
| Mus musculus | Rodents | TRL | TRL | ncbigene_synonym | T(10;11)Rl | 21033 |
| Mus musculus | Rodents | TRL | TRL | ncbigene_synonym | T(4;7)1Rl | 21186 |
| Mus musculus | Rodents | TRL | TRL | ncbigene_synonym | T(4;7)1Rl | 21187 |
| Mus musculus | Rodents | PCSK9 | PCSK9 | ncbigene_symbol | Pcsk9 | 100102 |
| Mus musculus | Rodents | LDLR | LDLR | ncbigene_symbol | Ldlr | 16835 |
| Mus musculus | Rodents | adipose | ADIPOSE | ncbigene_synonym | Wdtc1 | 230796 |
| Mus musculus | Rodents | LPL | LPL | ncbigene_symbol | Lpl | 16956 |
| Mus musculus | Rodents | SRB1 | SRB1 | ncbigene_synonym | Scarb1 | 20778 |
| Homo sapiens | Primates | B-AR | BAR | ncbigene_synonym | ADRB2 | 154 |
| Homo sapiens | Primates | B-AR | BAR | ncbigene_synonym | NR1H4 | 9971 |
| Homo sapiens | Primates | B-AR | BAR | ncbigene_synonym | BFAR | 51283 |
| Homo sapiens | Primates | PCSK9 | PCSK9 | ncbigene_symbol | PCSK9 | 255738 |
| Homo sapiens | Primates | LDLR | LDLR | ncbigene_symbol | LDLR | 3949 |
| Homo sapiens | Primates | LPL | LPL | ncbigene_symbol | LPL | 4023 |
| Homo sapiens | Primates | LPL | LPL | ncbigene_synonym | LCP1 | 3936 |
| Homo sapiens | Primates | SRB1 | SRB1 | ncbigene_synonym | SCARB1 | 949 |
| Homo sapiens | Primates | HDL | HDL | ncbigene_synonym | HSD11B1 | 3290 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | ALB | 213 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOA1 | 335 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOA2 | 336 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOE | 348 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | CLU | 1191 |
| Drosophila melanogaster | Invertebrates | Cold | COLD | ncbigene_symbol | cold | 33237 |
| Drosophila melanogaster | Invertebrates | B-AR | BAR | ncbigene_synonym | B-H2 | 32723 |
| Drosophila melanogaster | Invertebrates | B-AR | BAR | ncbigene_synonym | B-H1 | 32724 |
| Drosophila melanogaster | Invertebrates | B-AR | BAR | ncbigene_synonym | hh | 42737 |
| Drosophila melanogaster | Invertebrates | TRL | TRL | ncbigene_symbol | Trl | 2768981 |
| Drosophila melanogaster | Invertebrates | LDLR | LDLR | ncbigene_synonym | LRP1 | 35799 |
| Drosophila melanogaster | Invertebrates | LDLR | LDLR | ncbigene_synonym | modSP | 42032 |
| Drosophila melanogaster | Invertebrates | LDLR | LDLR | ncbigene_synonym | LpR2 | 43105 |
| Drosophila melanogaster | Invertebrates | LDLR | LDLR | ncbigene_synonym | mgl | 8674055 |
| Drosophila melanogaster | Invertebrates | HDL | HDL | ncbigene_symbol | Hdl | 44903 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Fatty acids | Fatty Acids | mesh:D005227 | fatty acid | chebi:35366 |
| Cholesterol | Cholesterol | mesh:D002784 | cholesterol | chebi:16113 |
| Bile acids | NA | mesh:D001647 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Atherosclerosis | NA | mesh:D050197 |